» Articles » PMID: 33219717

Risk Factors, Co-morbidities, and Co-medications in Cardioprotection: Importance for Translation

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2020 Nov 21
PMID 33219717
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Superior Anti-arrhythmogenic Effect of Combined Conditioning with Nicotinamide Mononucleotide and Ubiquinol in Myocardial Ischemia/Reperfusion Injury in Aged Rats.

Mokhtari B, Jessri A, Ghaffari S, Badalzadeh R Adv Pharm Bull. 2024; 14(3):686-695.

PMID: 39494250 PMC: 11530879. DOI: 10.34172/apb.2024.044.


Biological resilience in health and disease.

Weavers H Dis Model Mech. 2024; 17(7).

PMID: 39051470 PMC: 11552498. DOI: 10.1242/dmm.050799.


Is There a Mitochondrial Protection via Remote Ischemic Conditioning in Settings of Anticancer Therapy Cardiotoxicity?.

Kleinbongard P, Andreadou I Curr Heart Fail Rep. 2024; 21(4):292-304.

PMID: 38512567 PMC: 11333552. DOI: 10.1007/s11897-024-00658-w.


Perspective: mitochondrial STAT3 in cardioprotection.

Kleinbongard P Basic Res Cardiol. 2023; 118(1):32.

PMID: 37620559 PMC: 10449977. DOI: 10.1007/s00395-023-01003-3.


Mitoprotective effect of mesenchymal stem cells-derived conditioned medium in myocardial reperfusion injury of aged rats: role of SIRT-1/PGC-1α/NRF-2 network.

Nejati-Koshki K, Mokhtari B, Badalzadeh R, Arabzadeh A, Mohammadzadeh A Mol Biol Rep. 2023; 50(7):5655-5665.

PMID: 37199864 DOI: 10.1007/s11033-023-08499-x.


References
1.
Andreadou I, Schulz R, Badimon L, Adameova A, Kleinbongard P, Lecour S . Hyperlipidaemia and cardioprotection: Animal models for translational studies. Br J Pharmacol. 2019; 177(23):5287-5311. PMC: 7680007. DOI: 10.1111/bph.14931. View

2.
Ruiz-Meana M, Bou-Teen D, Ferdinandy P, Gyongyosi M, Pesce M, Perrino C . Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function. Cardiovasc Res. 2020; 116(11):1835-1849. DOI: 10.1093/cvr/cvaa132. View

3.
Ferdinandy P, Schulz R, Baxter G . Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007; 59(4):418-58. DOI: 10.1124/pr.107.06002. View

4.
Davidson S, Ferdinandy P, Andreadou I, Botker H, Heusch G, Ibanez B . Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 73(1):89-99. DOI: 10.1016/j.jacc.2018.09.086. View

5.
Kleinbongard P, Botker H, Ovize M, Hausenloy D, Heusch G . Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?. Br J Pharmacol. 2019; 177(23):5252-5269. PMC: 7680006. DOI: 10.1111/bph.14839. View